Clinical Trials Directory

Trials / Conditions / Renal Transplant Rejection

Renal Transplant Rejection

37 registered clinical trials studyying Renal Transplant Rejection4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMulti-Parametric MRI for Renal Transplantation
NCT03192007
University of Minnesota
Not Yet RecruitingDeep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes
NCT06438107
University of Pittsburgh
Not Yet RecruitingInduction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
NCT05385432
University Hospital, ToursPhase 3
WithdrawnNOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation
NCT05073822
University College, LondonPhase 1 / Phase 2
CompletedTorque Teno Virus: A Biomarker of Immunosuppression
NCT05756036
Queen Mary University of London
CompletedSwitch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant
NCT04530630
Weill Medical College of Cornell UniversityPhase 4
RecruitingStudy of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
NCT03707262
Jeffrey Veale, MDPhase 1 / Phase 2
Active Not RecruitingFostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
NCT03991780
Imperial College LondonPhase 1 / Phase 2
TerminatedHeme Arginate in Transplantation Study
NCT03646344
University of EdinburghPhase 3
TerminatedPathology and Imaging in Kidney Allografts
NCT03780101
NHS Greater Glasgow and Clyde
CompletedEnvarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transpla
NCT03511560
Columbia UniversityPhase 4
CompletedContrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
NCT02733029
Brigham and Women's HospitalPhase 2
CompletedDose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients
NCT03512431
Oslo University Hospital
CompletedProspective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Re
NCT02866682
University of California, Los AngelesPhase 4
CompletedUrine CXCL10 Chemokine Monitoring Post-renal Transplant
NCT03140514
University Hospital, Basel, SwitzerlandN/A
Active Not RecruitingVIRTUUS Children's Study
NCT03719339
Children's Hospital of Philadelphia
UnknownALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
NCT03422224
Medical University of Vienna
UnknownMRI in Renal Transplantation
NCT03705091
NHS Greater Glasgow and Clyde
CompletedTacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)
NCT04114188
Prof. Dr. Petra ReinkePhase 2
UnknownA Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection A
NCT02490020
Qipeng SunPhase 1
CompletedBelimumab Impacting Transplant Eligibility
NCT02500251
E. Steve WoodlePhase 1 / Phase 2
CompletedSteroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients
NCT02284464
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludPhase 4
CompletedTesting Immunosuppression Threshold in Renal Allografts To Extend eGFR
NCT02581436
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranN/A
UnknownMesenchymal Stromal Cell Therapy in Renal Recipients
NCT02057965
Leiden University Medical CenterPhase 2
CompletedMechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 10
NCT01953120
University of California, Los AngelesPhase 4
UnknownTo Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients
NCT02409940
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 1
CompletedSimulect Versus ATG in Sensitized Renal Transplant Patient
NCT02377193
University Hospital, ToulousePhase 4
CompletedImaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
NCT02006108
Stanford UniversityN/A
UnknownRenal Transplantation in the Elderly - nEverOld Study
NCT01631058
University of Sao Paulo General HospitalPhase 4
CompletedCytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
NCT01239472
Andre Barreto PereiraPhase 4
TerminatedCalcineurin Activity in Renal Recipients
NCT01413685
Assistance Publique - Hôpitaux de ParisPhase 4
CompletedProspective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipi
NCT00771745
University of CincinnatiPhase 4
CompletedInduction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts
NCT00658073
Fuzhou General HospitalN/A
CompletedRandomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients
NCT00866879
Northwestern UniversityPhase 4
TerminatedEfficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids
NCT01324934
Neovii BiotechPhase 3
TerminatedA Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
NCT00983645
Loma Linda UniversityPhase 4
CompletedThe Effect of Rituximab on the Development of Anti-Donor Antibodies
NCT00695097
University of California, San FranciscoN/A